Centiva Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$667K Buy
6,599
+3,037
+85% +$315K 0.01% 785
2026
Q1
$345K Buy
+3,562
New +$365K ﹤0.01% 1004
2025
Q1
Sell
-5,868
Closed -$542K 1693
2024
Q4
$542K Buy
+5,868
New +$576K 0.01% 773
2024
Q3
Sell
-6,993
Closed -$600K 2270
2024
Q2
$600K Buy
+6,993
New +$587K 0.01% 1035
2023
Q1
Sell
-5,205
Closed -$311K 1601
2022
Q4
$311K Buy
+5,205
New +$283K 0.01% 936
2022
Q1
Sell
-12,254
Closed -$640K 1678
2021
Q4
$636K Buy
12,254
+1,130
+10% +$58.3K 0.01% 731
2021
Q3
$665K Buy
+11,124
New +$700K 0.04% 514
2021
Q2
Sell
-10,330
Closed -$673K 1438
2021
Q1
$673K Buy
+10,330
New +$674K 0.03% 462
2020
Q4
Sell
-4,190
Closed -$217K 952
2020
Q3
$217K Buy
+4,190
New +$215K 0.01% 570

Other funds holding EHC

Centiva Capital's EHC Position: Q2 2026 in Review

Centiva Capital increased its Encompass Health (EHC) stake by 85% in Q2 2026, buying an estimated $315K and bringing the position to 6,599 shares worth $667K. The position accounts for 0.01% of the portfolio, ranked #785.

Centiva Capital first reported a position in EHC in Q3 2020 and has held it in 9 quarters since. The position peaked at $673K in Q1 2021. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Centiva Capital held 6,599 shares of Encompass Health worth $667K as of Q2 2026.
  • Centiva Capital bought 3,037 Encompass Health shares in Q2 2026, an estimated $315K.
  • Encompass Health made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #785 holding.
  • Centiva Capital first reported a position in Encompass Health in Q3 2020 and has held it in 9 quarters since.
  • Centiva Capital's Encompass Health position peaked at $673K in Q1 2021.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.